We are live on
!
Find out more
Los Angeles Capital Management Portfolio holdings
AUM
$27.2B
1-Year Est. Return
43.16%
This Fund
S&P 500
This Quarter
Est. Return
+13.16%
1 Year Est. Return
+43.16%
3 Year Est. Return
+177.72%
5 Year Est. Return
+262.7%
10 Year Est. Return
+1,121.27%
AUM
$22.5B
AUM Growth
+$1.93B
(+9.4%)
Cap. Flow
+$256M
Cap. Flow
% of AUM
1.14%
Top 10 Holdings %
Top 10 Hldgs %
26.61%
Holding
1,346
New
164
Increased
337
Reduced
605
Closed
194
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$426M |
| 2 |
Deere & Co
DE
|
+$212M |
| 3 |
NVIDIA
NVDA
|
+$149M |
| 4 |
W.W. Grainger
GWW
|
+$140M |
| 5 |
Netflix
NFLX
|
+$135M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$196M |
| 2 |
Home Depot
HD
|
+$189M |
| 3 |
Gilead Sciences
GILD
|
+$145M |
| 4 |
Oracle
ORCL
|
+$145M |
| 5 |
Microsoft
MSFT
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.24% |
| 2 | Financials | 13.5% |
| 3 | Healthcare | 12.02% |
| 4 | Consumer Discretionary | 11.94% |
| 5 | Industrials | 11.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1026
Boise Cascade
BCC
$2.93B
| $281K | ﹤0.01% |
4,442
-22,851
| -84% | -$1.58M |
|
1027
Sherwin-Williams
SHW
$87.5B
| $281K | ﹤0.01% |
1,248
-55,122
| -98% | -$12.6M |
|
|
DCPH
1028
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $280K | ﹤0.01% |
+18,118
| New | +$303K |
|
1029
Anika Therapeutics
ANIK
$287M
| $279K | ﹤0.01% |
9,710
-1,000
| -9% | -$29.8K |
|
1030
General Motors
GM
$75.8B
| $279K | ﹤0.01% |
7,601
-267
| -3% | -$10.1K |
|
1031
Saic
SAIC
$5.34B
| $279K | ﹤0.01% |
2,592
-5
| -0.2% | -$527 |
|
|
VGR
1032
DELISTED
Vector Group Ltd.
VGR
| $277K | ﹤0.01% |
+23,071
| New | +$291K |
|
1033
Terreno Realty
TRNO
$7.49B
| $277K | ﹤0.01% |
4,288
| – | – |
|
1034
Noodles & Co
NDLS
$98.6M
| $276K | ﹤0.01% |
7,123
-177
| -2% | -$8.08K |
|
|
GBIO
1035
DELISTED
Generation Bio
GBIO
| $276K | ﹤0.01% |
6,417
-116
| -2% | -$5.61K |
|
1036
Repligen
RGEN
$9.44B
| $274K | ﹤0.01% |
1,627
-3,899
| -71% | -$696K |
|
|
UNVR
1037
DELISTED
Univar Solutions Inc.
UNVR
| $274K | ﹤0.01% |
7,819
| – | – |
|
1038
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$5.41B
| $273K | ﹤0.01% |
9,562
+446
| +5% | +$14.1K |
|
|
TSVT
1039
DELISTED
2seventy bio
TSVT
| $273K | ﹤0.01% |
26,749
-510
| -2% | -$5.83K |
|
1040
Cloudflare
NET
$118B
| $273K | ﹤0.01% |
4,424
-73,462
| -94% | -$4.02M |
|
|
BPMC
1041
DELISTED
Blueprint Medicines
BPMC
| $273K | ﹤0.01% |
6,061
+899
| +17% | +$40.5K |
|
1042
Armstrong World Industries
AWI
$7.74B
| $271K | ﹤0.01% |
3,811
| – | – |
|
1043
Herbalife
HLF
$1.27B
| $270K | ﹤0.01% |
+16,789
| New | +$297K |
|
1044
Mitek Systems
MITK
$842M
| $268K | ﹤0.01% |
27,947
-720
| -3% | -$6.91K |
|
1045
DoorDash
DASH
$93.5B
| $266K | ﹤0.01% |
4,191
-319,879
| -99% | -$18.3M |
|
1046
Moderna
MRNA
$25.1B
| $266K | ﹤0.01% |
1,733
-32,927
| -95% | -$5.43M |
|
1047
WEX
WEX
$6.69B
| $266K | ﹤0.01% |
+1,445
| New | +$263K |
|
1048
Clearfield
CLFD
$396M
| $266K | ﹤0.01% |
5,703
-110
| -2% | -$7.09K |
|
1049
MACOM Technology Solutions
MTSI
$24.1B
| $264K | ﹤0.01% |
3,725
-31,678
| -89% | -$2.14M |
|
1050
Emerson Electric
EMR
$90.9B
| $264K | ﹤0.01% |
3,024
-116
| -4% | -$10.1K |
|
Similar funds
FDCDDQ
WP
N
PCH
VAI
Los Angeles Capital Management's Q1 2023 Portfolio in Review
As of Q1 2023, Los Angeles Capital Management held 1,346 positions worth $22.5B, up 9.4% from $20.6B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Los Angeles Capital Management's Q1 2023 filing shows 164 new, 337 increased, 605 reduced and 194 closed positions. Its largest new stake was Bio-Rad Laboratories Class A: 184,796 shares worth $88.5M. The largest sale was Pfizer, an estimated $196M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 28% a quarter earlier, followed by Financials and Healthcare.
- Los Angeles Capital Management's largest Q1 2023 buy was Bio-Rad Laboratories Class A: 184,796 shares worth $88.5M.
- Los Angeles Capital Management added most to Visa in Q1 2023, an estimated $426M increase.
- Los Angeles Capital Management's biggest Q1 2023 reduction was Pfizer, cutting an estimated $196M.
- Los Angeles Capital Management fully exited Regions Financial in Q1 2023, selling an estimated $50.4M.
- Los Angeles Capital Management's ten largest holdings make up 27% of its $22.5B portfolio in Q1 2023.
- Los Angeles Capital Management opened 164 new positions and closed 194 in Q1 2023.
- Los Angeles Capital Management's portfolio value rose 9.4% quarter-over-quarter to $22.5B.
Based on Los Angeles Capital Management's 13F filing for Q1 2023, filed 4 May 2023.